You can buy Pomalid at the lowest price in the online pharmacy Nextgen.ooo . Pomalidomide is a thalidomide analogue used in combination with dexamethasone to treat patients with multiple myeloma.
Pomalidomide, a thalidomide analogue, is an immunomodulatory antineoplastic agent. It was approved by the FDA on February 8, 2013.
 
Pomalidomide is indicated for patients with multiple myeloma who have received at least two prior therapies, including lenalidomide and bortezomib, and have demonstrated disease progression within 60 days of completion of the last therapy or within 60 days of completion of the last therapy. Pomalidomide is more effective than thalidomide (100-fold) and lenalidomide (10-fold).
 
Promalidomide is an immunomodulatory agent with antineoplastic activity. It has been shown to suppress proliferation and induce apoptosis of various tumor cells. In addition, promalidomide enhances T-cell and natural killer (NK)-mediated immunity and suppresses the production of proinflammatory cytokines such as TNF-alpha or IL-6 by monocytes. The main target of pomalidomide is believed to be the cerblon protein. It binds to this target and inhibits ubiquitin ligase activity. It is also an inhibitor of COX2 transcription.